Geoff Drenkhahn
Head, Business Development and Commercial Operatio
Life Sciences
Burnet Institute
Australia
Biography
Geoff Drenkhahn is an executive with 20+ years of experience in the R+D sector with a record of identifying opportunities and developing strategies for expansion and growth, and building new business operations.
Research Interest
He currently represents Burnet on the board of four independent entities developing and commercialising Burnet technologies, Nanjing BioPoint, HepSeeVax, 360biolabs and Optima Consortium for Decision Science (OCDS).
